DONGFENG GROUP
00489
GUANGDONG INV
00270
YUEXIU PROPERTY
00123
KB LAMINATES
01888
CONCH CEMENT
00914
HK Stock MarketDetailed Quotes
02607 SH PHARMA
- 13.440
- +0.160+1.20%
Trading Dec 12 15:07 CST
49.83BMarket Cap11.16P/E (TTM)
13.480High13.260Low1.49MVolume13.260Open13.280Pre Close19.94MTurnover0.16%Turnover Ratio11.99P/E (Static)3.71BShares14.70052wk High0.63P/B12.35BFloat Cap9.65252wk Low0.53Dividend TTM919.07MShs Float24.612Historical High0.440Dividend LFY1.66%Amplitude2.037Historical Low13.429Avg Price100Lot Size3.93%Div YieldTTM3.27%Div Yield LFY
About SH PHARMA Company
The company is a large pharmaceutical industry group listed in Shanghai and Hong Kong. The main business covers the pharmaceutical industry and commerce, and ranks among the Fortune 500 and the top 50 global pharmaceutical companies. Its comprehensive strength ranks in the top three Chinese pharmaceutical companies, and is selected as a constituent stock of the Shanghai Composite 180 Index, the Shanghai and Shenzhen 300 Index, and the Morgan Stanley China Index (MSCI). The company's main business covers the pharmaceutical industry and pharmaceutical business. The company's main products: hydroxychloroquine sulfate tablets, injectable usastatin, tanshinone IIA sodium sulfonate injections, polysaccharide iron complex capsules, and bifidobacteria trifecta active bacterial preparations. Corporate honors: “2023 Asia Pacific Quality Organization - Innovation Award”, the company won 27 national quality awards, 112 provincial and municipal quality awards, the “Fortune 500” list, and won the “Top 50 Global Pharmaceutical Companies”, “Top 25 Global Pharmaceutical Brands”, “China's Top 100 Pharmaceutical Industry Companies”, and “China's Top 100 Pharmaceutical Industry Companies”, and “Best Industrial Enterprise in China's Pharmaceutical R&D Product Line”, ranked 473rd among the 2020 Fortune Global 500, and is one of only two Chinese pharmaceutical companies; In “Fortune It ranked 57th in the 2020 Fortune China 500 published by “Fortune” (Chinese version); ranked 1009th in the 2020 Global Top 2000 Companies published by “Forbes”; and ranked 2nd in the overall strength of China Pharmaceutical Group;
Company Profile
Symbol02607
Company NameSH PHARMA
ISINCNE1000012B3
Listing DateMay 20, 2011
Issue Price23.00
Shares Offered664.21M share(s)
FoundedJan 18, 1994
Registered AddressChina
Chairmanqiuhua yang
Secretarytaohuangpeiqiao zhong
Audit InstitutionDeloitte Huayong Certified Public Accountants (Special General Partnership)
Company CategoryMainland registration of Mainland State-owned Assets control
Registered OfficeNo. 92, Zhangjiang Road, China (Shanghai) Pilot Free Trade Zone
Head Office and Principal Place of Business5th Floor, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees49234
MarketHong Kong motherboard
Phone8621-63730908
Fax8621-63289333
Emailpharm@sphchina.com
Websitehttp://www.sphchina.com
BusinessPharmaceutical products of various dosage forms (including but not limited to tablets, capsules, aerosols, immunological preparations, granules, ointments, pills, oral solutions, inhalants, injections, liniments, tinctures, suppositories) (including but not limited to the development of chemical raw materials, chemical preparations, Chinese herbal medicines, proprietary Chinese medicines, Chinese herbal medicines, herbal medicines, biological products, narcotic drugs, psychotropic drugs, toxic drugs for medical use [appropriate to the scope of business], vaccines), health products, medical devices and related products Manufacturing and sales, pharmaceutical equipment manufacturing, sales and engineering installation, maintenance, warehousing and logistics, offshore , land and air freight forwarding business, industrial investment, asset management, provision of international economic and trade information and consulting services, leasing of own housing, and import and export business of various kinds of pharmaceuticals and related commodities and technology (the above involves licensed operations).
Company Executives
- Name
- Position
- Salary
- qiuhua yang
- Chairman, Executive Director, Chairman of the Strategy Committee, Remuneration Committee Member
- --
- bo shen
- President, Executive Director, Chief Financial Officer, Nomination Committee Members, Authorized Representative
- 5.80M
- yongzhong li
- Executive President, Executive Director
- 6.19M
- ming dong
- Executive Director
- --
- wenxue zhang
- Non-executive Directors, Strategy Committee Members
- --
- chaoyang gu
- Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Remuneration Committee Members
- 300.00K
- wenxun huo
- Independent Non-Executive Director, Chairman of the Nomination Committee, Audit Committee Members
- 300.00K
- zhong wang
- Independent Non-Executive Director, Remuneration Committee Chairman, Strategy Committee Member, Audit Committee Member
- 150.00K
- youli xu
- Chief Supervisor
- --
- weidong yu
- Employee Representative Supervisor
- --
- jia ma
- Auditors
- --
- yong zhao
- VP
- --
- jianyi mao
- VP
- --
- yaohua zhang
- VP
- --
- tao zhong
- VP, Joint Company Secretary, Board Secretary, Authorized Representative
- --
- dongming li
- VP
- --
- maitiaili mai
- VP
- --
- shuai shao
- VP
- --
- peiqiao huang
- Joint Company Secretary, Legal Process Agent
- --
Trending HK Stocks
HK Dividend Stocks HK Dividend Stocks
Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.
